Accelerated Brain Volume Loss Caused by Anti–β-Amyloid Drugs

These findings reveal the potential for anti-Aβ therapies to compromise long-term brain health by accelerating brain atrophy and provide new insight into the adverse impact of ARIA. Six recommendations emerge from these findings.